|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1994-2-9
|
|
pubmed:abstractText |
The purpose of this study was to assess the efficacy of 150 mg of aspirin plus 100 mg of alteplase, administered as two intravenous bolus injections of 50 mg each given 30 min apart, and followed by intravenous heparin, on infarct-related coronary artery patency (Thrombolysis in Myocardial Infarction [TIMI] flow grade 3).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
6-10
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8277097-Adult,
pubmed-meshheading:8277097-Aged,
pubmed-meshheading:8277097-Coronary Angiography,
pubmed-meshheading:8277097-Female,
pubmed-meshheading:8277097-Humans,
pubmed-meshheading:8277097-Injections, Intravenous,
pubmed-meshheading:8277097-Male,
pubmed-meshheading:8277097-Middle Aged,
pubmed-meshheading:8277097-Myocardial Infarction,
pubmed-meshheading:8277097-Pilot Projects,
pubmed-meshheading:8277097-Prospective Studies,
pubmed-meshheading:8277097-Thrombolytic Therapy,
pubmed-meshheading:8277097-Tissue Plasminogen Activator,
pubmed-meshheading:8277097-Vascular Patency
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction.
|
|
pubmed:affiliation |
Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
